Hostname: page-component-78c5997874-t5tsf Total loading time: 0 Render date: 2024-11-14T06:57:11.865Z Has data issue: false hasContentIssue false

Barriers and facilitators associated with pharmacological treatment in bipolar disorder patients

Published online by Cambridge University Press:  13 August 2021

J.Á. Alcalá Partera*
Affiliation:
Clinical Unit Of Mental Health., Reina Sofia University Hospital., Córdoba., Spain
A. Fontalba Navas
Affiliation:
Antequera., Northern Málaga Integrated Healthcare Area., Málaga., Spain
M. Company Morales
Affiliation:
Faculty Of Nursing, Physiotherapy And Medicine., University of Almeria., Almería, Spain
S.L. Romero Guillena
Affiliation:
Clinical Unit Of Mental Health., Virgen Macarena University Hospital., Sevilla, Spain
T. Gutiérrez Higueras
Affiliation:
Clinical Unit Of Mental Health., Reina Sofia University Hospital., Córdoba., Spain
F. Calera Cortés
Affiliation:
Clinical Unit Of Mental Health., Reina Sofia University Hospital., Córdoba., Spain
S. Vicent Forés
Affiliation:
Clinical Unit Of Mental Health., Reina Sofia University Hospital., Córdoba., Spain
L. Gutiérrez Rojas
Affiliation:
Department Of Psychiatry., University of Granada., Granada, Spain
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

The main factors that are involved in a correct adherence to the therapeutic recommendations in Bipolar Disorder includes aspects related to age, sex, ethnicity, socioeconomic level and characteristics of the illness associated with the severity, comorbidity and adverse effects related to previous medicine.

Objectives

To analyse the individual perception that the patient with Bipolar Disorder has regarding the positive and negative aspects of taking the recommended medication.

Methods

Descriptive and interpretative observational study under the qualitative paradigm of research, extracting the data through the completion of four focus groups with ten patients everyone. To complete the codification of the content of the participant’s discourses, we rely on the QRS NVivo 10 computer program.

Results

In the participant’s discourse concerning the main barriers to pharmacological treatment, for example “It’s because we live in a society and, because of that, we don’t go without medicine; if we didn’t live in society, we wouldn’t take medicine because we wouldn’t bother anyone”. Some examples of patient’s discourse, about perceived facilitators were: “I have to take medicine for my bipolar disorder, that’s it, I have a treatment, my illness has a name”.

Conclusions

The main facilitators regarding the use of pharmacological treatment in Bipolar Disorder are the perceived need for treatment in the acute phase and the recognition of the illness, the shared clinical decision and the causal biological attribution in the chronic phase. About perceived barriers, social control is identified in both phases, adverse effects in the acute cases and the absence of effective treatment in the chronic state.

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2021. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.